Dimethylformamide → 1-[4-amino-5-(2-benzyl-2H-indazol-6-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-morpholin-4-ylethanone

HRID 1972821Notes

Reaction equation

HRID 1972821 reaction equation
[NH2:1][C:2]1[C:7]2=[C:8](Br)[CH:9]=[C:10]([C:11](=[O:19])[CH2:12][N:13]3[CH2:18][CH2:17][O:16][CH2:15][CH2:14]3)[N:6]2[N:5]=[CH:4][N:3]=1.CN(C=O)C.[CH2:26]([N:33]1[CH:41]=[C:40]2[C:35]([CH:36]=[C:37](B3OC(C)(C)C(C)(C)O3)[CH:38]=[CH:39]2)=[N:34]1)[C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1.C([O-])([O-])=O.[K+].[K+]>O1CCOCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.O>[NH2:1][C:2]1[C:7]2=[C:8]([C:37]3[CH:38]=[CH:39][C:40]4[C:35]([CH:36]=3)=[N:34][N:33]([CH2:26][C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=3)[CH:41]=4)[CH:9]=[C:10]([C:11](=[O:19])[CH2:12][N:13]3[CH2:18][CH2:17][O:16][CH2:15][CH2:14]3)[N:6]2[N:5]=[CH:4][N:3]=1

Participants

8

Reactant 4

HCID 6228DimethylformamideHCID 11430Potassium CarbonateHCID 585293132-benzyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-IndazoleHCID 585294241-(4-Amino-5-bromopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-morpholin-4-ylethanone

Product 1

HCID 585296201-[4-amino-5-(2-benzyl-2H-indazol-6-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-morpholin-4-ylethanoneYield 16%

Reagents, catalysts & solvents 3

HCID 178418397HCID 178418397, compoundCatalystHCID 962WaterSolventHCID 312751,4-DioxaneSolvent

Conditions

Temperature
100 °C

Procedure

To a stirred solution of 1-(4-amino-5-bromopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-morpholin-4-ylethanone (90 mg, 0.27 mmol) and tetrakis(triphenylphosphine)palladium(0) (61 mg, 0.05 mmol), in degassed 1,4-dioxane (1.0 mL) and DMF (2.0 mL) was added 2-benzyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole (97 mg, 0.29 mmol), K2CO3 (80 mg, 0.58 mmol), and H2O (0.3 mL). The mixture was degassed and heated (100° C.) for 17 h and then cooled to rt. The mixture was partitioned between ethyl acetate (25 mL) and saturated aqueous K2CO3 solution (25 mL). The layers were separated and the organic phase was washed, dried (Na2SO4), and concentrated to dryness. The residue was purified by preparative HPLC using a gradient elution from 10% to 70% acetonitrile to obtain 20 mg (16%) of the desired product. 1H-NMR (DMSO-d6) 8.57 (s, 1H), 8.13 (s, 1H), 7.82 (d, 1H), 7.65 (s, 1H), 7.39 (s, 1H), 7.36-7.28 (m, 5H), 7.14 (d, 1H), 5.65 (s, 2H), 3.93 (s, 2H), 3.58-3.56 (m, 4H), 2.56-2.53 (m, 4H); LC-MS [M+H]+=468, RT=2.27 min.

Workup

  1. customThe mixture was degassed
  2. temperaturecooled to rt
  3. customThe mixture was partitioned between ethyl acetate (25 mL) and saturated aqueous K2CO3 solution (25 mL)
  4. customThe layers were separated
  5. washthe organic phase was washed
  6. dry with materialdried (Na2SO4)
  7. concentrationconcentrated to dryness
  8. customThe residue was purified by preparative HPLC
  9. washa gradient elution from 10% to 70% acetonitrile

Sources & evidence

ORD record
ord-fdfee513b19a4e6b81336cf7d54959b4
Source dataset
uspto-grants-2013_04
Patent number
US08431695B2

Reaction notes

Loading…